Small-cap picks split as cash alone falls short

By early October 2026, the Russell 2000 stock-picking conversation was already being shaped by repeated StockStory screens that paired a single favored small-cap with multiple names to avoid. In one May example, StockStory wrote that “here is one small-cap stock that could be the next 100 bagger and two best left ignored,” naming “One Small-Cap Stock to Watch: BioMarin Pharmaceutical (BMRN)” and “Two Small-Cap Stocks to Sell” Mission Produce and Lemonade; the split was explicit, with BMRN backed by “14.5% annual revenue growth over the last two years” and “Projected revenue growth of 26.5%,” while AVO faced a “Projected sales decline of 17%,” and LMND was faulted because “Policy losses and capital returns have eroded its book value per share this cycle as its book value per share declined by 18.4% annually over the last five years” alongside “Negative return on”.

That same buy-versus-avoid framing kept surfacing across small-cap coverage, reinforcing that this was not a one-off call but a recurring selection pattern. StockStory’s May 26 headline, “1 Small-Cap Stock with Solid Fundamentals and 2 That Underwhelm,” again said “here is one small-cap stock that could be the next 100 bagger and two best left ignored,” this time favoring Astec because “Estimated revenue growth of 12.9% for the next 12 months” and “Operating margin improvement of 4.6 percentage points” contrasted with Dropbox, where “Flat billings over the last year” and “Projected sales for the next 12 months are flat,” and Goodyear, where “Negative free cash flow” accompanied a 56.8% annual EPS drop.

What is emerging is not a simple preference for cash-rich balance sheets, but a stricter test of what that cash is actually doing. StockStory made that rule explicit, arguing that profitability or cash generation alone does not make “a great investment” if a company cannot “reinvest wisely,” and its examples followed that logic: Ralph Lauren was an avoid because of “Underwhelming constant currency revenue performance over the past two years” and a “Forecasted free cash flow margin” that would not improve cash conversion, while Murphy Oil drew caution after expenses swelled relative to revenue and EBITDA margin fell 11.7 points. The same framework showed up in “Two Stocks to Sell: Tractor Supply (TSCO),” where a “Trailing 12-Month Free Cash Flow Margin: 3.5%” was not enough to offset “below-average annual revenue increases of 2.6% for the last three years” and “Poor same-store sales performance.”

The flip side is that investors are rewarding companies where cash strength is visibly turning into stronger growth, earnings, and operating leverage. Ryan Specialty was the positive template, with “Annual revenue growth of 20.5% over the past two years,” EPS growth of 16.2% annually, and a 17.5% free-cash-flow margin that “gives it many options,” while Monolithic Power Systems paired a 22.2% free-cash-flow margin with 25.9% annual revenue growth and 27.7% EPS growth; by contrast, even cash-generative names such as Deckers, Gap, and Illumina were penalized when growth was below standards, sales were flat or stagnant, or capital deployment looked ineffective. In “Two best left off your watchlist,” for example, Deckers (DECK) posted a “Trailing 12-Month Free Cash Flow Margin: 20.1%,” but the critique was still fundamental because “Constant currency growth was below our standards over the past two” years, while “Two Stocks to Sell: Gap (GAP) … Trailing 12-Month Free Cash Flow Margin: 7.3%” was undermined by “Flat sales over the last three years” and the view that “Limited expansion of stores suggests it’s prioritizing efficiency over growth.”

What marks the winners is not cash by itself but cash paired with visible operating acceleration. StockStory highlighted Clover Health and Oscar Health as companies that “excel at turning cash into shareholder value”: Clover posted “Annual revenue growth of 31.2% over the last two years,” “Adjusted operating margin improvement of 25.6 percentage points over the last five years,” and a “Free cash flow profile has moved into positive” territory, while Oscar delivered “Impressive 42.6% annual revenue growth over the last two years,” EPS compounding of 31.5% annually, and a 19.9-point expansion in free-cash-flow margin.

The same pattern appears across other favored names: Blue Bird was StockStory’s “One Industrials Stock to Buy,” with “Annual revenue growth of 14.3% over the last five years,” “Free cash flow margin expanded by 21 percentage points,” and “Rising returns on capital,” while KLA combined 15.2% annual revenue growth, a 30.5% free-cash-flow margin, and a 40% operating margin; Curtiss-Wright added 11% annual revenue growth and a 6.3-point free-cash-flow margin jump; and for Palantir Technologies, “Billings growth has averaged 67.6% over the last year, indicating a healthy pipeline of new contracts that should drive future revenue increases.” By contrast, Monro’s “Recent store closures and weak same-store sales” and OPENLANE’s flat sales show why investors are rewarding cash that compounds, not cash that merely sits on the balance sheet.

What separates the small-cap rejects is not the absence of cash-like balance-sheet appeal, but the presence of operating decay. StockStory’s case against Hudson Technologies was blunt: “Sales tumbled by 4.7% annually over the last two years” while “Eroding returns on capital suggest its historical profit centers are aging,” and Knowles showed the same pattern, with “sales have declined by 5.2% annually over the last five years” as “Earnings per share lagged its peers over the last five years as they only grew by 5.2% annually,” even before considering that “Knowles’s stock price of $36.92 implies a valuation ratio of 28x forward P/E.”

That value-trap pattern repeats across names StockStory explicitly put in the sell bucket: “Two Small-Cap Stocks to Sell: Ollie’s (OLLI)” and “Avis Budget Group (CAR)” while presenting “One Small-Cap Stock to Buy: QuinStreet (QNST)” with “Impressive 47.2% annual revenue growth over the last” two years. CAR had “Annual sales declines of 1% for the past two years” and “Diminishing returns on capital suggest its earlier profit pools are drying up,” alongside “Short cash runway,” while “Two Stocks to Sell: KB Home (KBH)” and “Selective Insurance Group (SIGI)” were marked by “Demand cratered,” a 28% backlog decline, falling EPS, and at SIGI, “Estimated sales growth of 1.7%” plus a pre-tax margin down 3.2 points.

The market backdrop is making broad small-cap exposure harder to own without a filter. ETFDb argued the Russell 2000 “has a lot of stocks that are unprofitable,” and while those names “can go up when the market is rearing higher,” “when there's some volatility in the marketplace” quality matters more; in that setting, the index’s mix of weaker businesses makes profitability-focused approaches more relevant, with the speaker saying a strategy like Avantis works because of “that quality filter” applied on an active basis.

That preference for quality is being reinforced by both index-level turbulence and active-manager behavior. ETFDb noted that “At the start of this year, the Russell 2000 was trading at 18 times forward earnings versus 26 for the S&P 500,” after a discount that had reached a 25-year extreme, and said “an index that has profitability screens and invest in small caps is arguably doing better than the Russell 2000 itself” because it screens out companies that “don't make money”; StockStory showed the same instinct in practice, saying industrials had “shed 1.5% over the past six months” versus the S&P 500’s 10.9% gain while framing its selection as “one resilient industrials stock at the top of our wish list and two we’re steering clear of,” then listing HRI as a sell because its “operating margin fell by 7 percentage points” and “earnings” weakened.